Editorial: T-Cell and Antibody-Mediated Rejection After Organ Transplantation in the Post-COVID-19 Era - Diagnosis, Immunological Risk Evaluation and Therapy.

Slavcev, Antonij; Süsal, Caner; Doxiadis, Ilias

Slavcev, Antonij; Süsal, Caner; Doxiadis, Ilias.

Slavcev A; Department of Immunogenetics, Institute for Clinical and Experimental Medicine, Prague, Czechia.
Süsal C; Transplant Immunology Research Center of Excellence, Koç University Hospital, Istanbul, Turkey.
Doxiadis I; Institute for Transfusion Medicine, University Hospital, Leipzig, Germany.

Front Immunol ; 13: 968668, 2022.

Article in English | MEDLINE | ID: covidwho-1963489

Subject(s)

COVID-19; Organ Transplantation; Graft Rejection/diagnosis; Humans; Immunologic Tests; Organ Transplantation/adverse effects; T-Lymphocytes

Keywords

COVID - 19; HLA; T cell mediated rejection; antibody-mediated rejection; molecular microscope

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Organ Transplantation / COVID-19 Type of study: Diagnostic study / Experimental Studies / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Front Immunol Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google